BioCentury
ARTICLE | Company News

Alizyme, Pharmagenix deal

February 28, 2011 8:00 AM UTC

Grant Thornton U.K. LLP, which is serving as Alizyme's administrator after the biotech entered administration in 2009, disclosed that Pharmagenix acquired Alizyme's ATL-104 for £67,250 ($109,161) last...